An article on the front of the Life & Arts section in
Sunday’s Buffalo News reports on the work of Kate
Rittenhouse-Olson, professor of biotechnical and clinical
laboratory sciences, who created a new cancer-fighting antibody,
and has started a company, For-Robin, to develop a marketable
cancer therapy. She has been awarded hundreds of thousands of
dollars from the National Cancer Institute and UB to begin the next
phase of testing on her breakthrough.